Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function

Circulation

Volumn 104, Issue 10, 2001, Pages 1101-1107

  Choi, Kelly M ^a   Kim, Raymond J ^a   Gubernikoff, George ^a   Vargas, John D ^a   Parker, Michelle ^a   Judd, Robert M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Contrast media; Magnetic resonance imaging; Myocardial infarction

Indexed keywords

CONTRAST MEDIUM; GADOTERIDOL;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE CONTRACTILITY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL;

EID: 0035806915     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc3501.096798     Document Type: Article

References (35)

1. Salvage of myocardial function by coronary artery reperfusion 1, 2, and 3 hours after occlusion in conscious dogs
2. The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction: A 12-month follow-up report
3. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
4. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
5. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombolysis (ASSET)
6. Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study: Anglo-Scandinavian Study of Early Thrombolysis
7. Sustained regional dysfunction produced by prolonged coronary stenosis: Gradual recovery after reperfusion
8. Dobutamine stress echocardiography for detection and assessment of coronary artery disease
9. The "wavefront phenomenon" of myocardial ischemic cell death, II: Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow
10. Myocardial infarct size and location in relation to the coronary vascular bed at risk in man
11. Improved regional ventricular function after successful surgical revascularization
12. Optimal criteria for rapid detection of myocardial reperfusion by creatine kinase MM isoforms in the presence of residual high grade coronary stenosis
13. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function
14. Contrast-enhanced magnetic resonance imaging of myocardium at risk: Distinction between reversible and irreversible injury throughout infarct healing
15. Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging
16. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction
17. An improved MR imaging technique for the visualization of myocardial infarction
18. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction
19. The wavefront phenomenon of ischemic cell death, I: Myocardial infarct size vs duration of coronary occlusion in dogs
20. Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction
21. Contractile reserve and contrast uptake pattern by magnetic resonance imaging and functional recovery after reperfused myocardial infarction
22. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging
23. Dobutamine echocardiography in myocardial hibernation: Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty
24. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography
25. Estimation of acute myocardial infarct size in man by serum CK-MB measurements
26. Effects of coronary artery reperfusion on myocardial infarct size calculated from creatine kinase
27. Patterns of creatine kinase release during acute myocardial infarction after nonsurgical reperfusion: Comparison with conventional treatment and correlation with infarct size
28. Enzymatic estimation of infarct size during reperfusion
29. Effects of coronary artery reperfusion on relation between creatine kinase-MB release and infarct size estimated by myocardial emission tomography with thallium-201 in man
30. Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction: Results of thrombolysis and angioplasty in myocardial infarction phase 5 randomized trial: TAMI Study Group
31. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction
32. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial
33. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction: The GUSTO Angiographic Investigators
34. Extended mortality benefit of early postinfarction reperfusion. GUSTO-I Angiographic Investigators: Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Trial